Senate and House health committee leaders reached an agreement to renew programs that fund key FDA programs for another five years.
Sen. Richard Burr speaks to Sen. Patty Murray before a Senate committee hearing to examine the federal response to COVID-19 on Jan. 11. Photo: Greg Nash/Pool/AFP
Senate and House health committee leaders on Thursday reached an agreement to renew programs that fund key Food and Drug Administration programs for another five years.Without congressional action by the end of the month, the FDA would have started sending out furlough notices to staff and slowed down critical work like drug approvals.
The deal covers user fees that industries pay to fund drug, device and other product evaluations and is due to be attached to a stopgap spending bill to keep the government funded into December.The agreement tracks with Republicans' wishes for a "clean" bill without policy changes that would have
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Updated boosters for elementary school-aged children 'weeks' from authorization: FDA vaccine chiefNew boosters for 5- to 11-year-olds are just weeks away from authorization, says the vaccine chief at the Food and Drug Administration, Dr. Peter Marks.
Read more »
FDA acknowledges delays in response to baby formula shortageA 10-page report from the agency offers its first formal account of the factors that led to the ongoing shortage.
Read more »
FDA Admits Flaws in Response to Infant Formula ShortageIn a report issued Tuesday, the U.S. Food and Drug Administration acknowledged numerous shortcomings in its response to the infant formula shortage earlier this year.
Read more »
FDA warning: Ignore that TikTok challenge nonsense and don't cook chicken with NyQuilApparently, some of you needed to hear the FDA warning that the so-called 'sleepy chicken' TikTok challenge is unsafe.
Read more »
FDA releases more doses of Moderna’s updated Covid-19 boosters amid reports of ‘limited’ supplyUpdated boosters from Pfizer/BioNTech and Moderna were made available early this month, soon after the FDA authorized them. However, some pharmacy chains have reported trouble keeping Moderna&8217…
Read more »